Paper38242
Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine).
Griffith OW and 1 other. J Biol Chem, 1979. Cited by 1,462 papers, by iCite.
Cite this record
ConductScience Library. Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine). Papers, record 38242. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38242
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine).
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glutamate-Cysteine Ligase | Major topic |
| Glutathione | Major topic |
| Methionine Sulfoximine | Major topic |
| Peptide Synthases | Major topic |
| Kinetics | |
| Structure-Activity Relationship |
Source PubMed
Cited by413
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,462 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42792126 | Skin Histology of Pithecopus spp. and Modulation of Glutathione Status by the Antioxidant Tryptophyllin PaT-2. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/42792126 | PubMed |
| 42762415 | NRF2 signaling drives chemoresistance in NSCLC and glioblastoma. | Mol Cell Biochem | 2026 | https://conductscience.org/library/papers/42762415 | PubMed |
| 42466747 | Engineered Substrates for a Sulfurtransferase Enhance Endogenous Hydropersulfides and Inhibit Ferroptosis. | Angew Chem Int Ed Engl | 2026 | https://conductscience.org/library/papers/42466747 | PubMed |
| 42412619 | Targeting Cystine Addiction Suppresses Breast Cancer Lung Metastasis. | Cancer Res | 2026 | https://conductscience.org/library/papers/42412619 | PubMed |
| 42377466 | Peroxisomal catalase and plasmalogen biosynthesis protect from oxidative stress in Barth syndrome cardiomyopathy. | Basic Res Cardiol | 2026 | https://conductscience.org/library/papers/42377466 | PubMed |
| 42232504 | Targeting the Mitochondrial Phenotype in Cockayne Syndrome Patient Cells: From Bioenergetic Fragility to Pharmacologic Rescue. | bioRxiv | 2026 | https://conductscience.org/library/papers/42232504 | PubMed |
| 41959261 | Systematic Evaluation Defines the Limits of Ferroptosis in Cancer Therapy. | bioRxiv | 2026 | https://conductscience.org/library/papers/41959261 | PubMed |
| 41692318 | Deuterated polyunsaturated fatty acids alleviate in vitro skeletal muscle dysfunction induced by oxidative stress. | Free Radic Biol Med | 2026 | https://conductscience.org/library/papers/41692318 | PubMed |
| 41613499 | The Hallmarks of Ferroptosis. | Annu Rev Cancer Biol | 2019 | https://conductscience.org/library/papers/41613499 | PubMed |
| 41523578 | ROS-activatable Prodrug of Doxazolidine as Novel Cancer Therapy Paradigm. | Adv Ther (Weinh) | 2024 | https://conductscience.org/library/papers/41523578 | PubMed |
| 41509286 | Deuterated Polyunsaturated Fatty Acids Alleviate In Vitro Skeletal Muscle Dysfunction Induced by Oxidative Stress. | bioRxiv | 2025 | https://conductscience.org/library/papers/41509286 | PubMed |
| 41501350 | Tocotrienols exhibit superior ferroptosis inhibition over tocopherols. | Sci Rep | 2026 | https://conductscience.org/library/papers/41501350 | PubMed |
| 41373985 | Protective Role of Ginsenoside F1-Enriched Extract (SGB121) in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD). | Nutrients | 2025 | https://conductscience.org/library/papers/41373985 | PubMed |
| 41347142 | Loss of Nocturnin increases neuronal viability in oxidative stress conditions. | Front Neurosci | 2025 | https://conductscience.org/library/papers/41347142 | PubMed |
| 41333220 | The implication of aberrant NRF2 activation in management of female cancers. | Front Oncol | 2025 | https://conductscience.org/library/papers/41333220 | PubMed |
| 41290624 | Non-canonical roles of Keap1/Nrf2 in regulating quiescence and early activation in adult muscle stem cells. | Nat Commun | 2025 | https://conductscience.org/library/papers/41290624 | PubMed |
| 40826242 | Prospects for ferroptosis therapies in cancer. | Nat Cancer | 2025 | https://conductscience.org/library/papers/40826242 | PubMed |
| 40823867 | Synergistic activity of RSL3 and Pyrimethamine to inhibit the proliferation of Plasmodium falciparum. | Antimicrob Agents Chemother | 2025 | https://conductscience.org/library/papers/40823867 | PubMed |
| 40772229 | Inhibiting the RNA helicase DDX3X in Burkitt lymphoma induces oxydative stress and impedes tumor progression in xenografts. | Front Cell Dev Biol | 2025 | https://conductscience.org/library/papers/40772229 | PubMed |
| 40681773 | PHLPP1 regulates region-specific astroglial mitochondrial fission in response to oxidative stress in the male rat hippocampus. | Sci Rep | 2025 | https://conductscience.org/library/papers/40681773 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38242
GET https://conductscience.org/api/papers/v1/38242/cited_by?page=2